# Hetero Drugs Ltd. - Unit 1 – FDA Inspection, Feb 25, 2016

Source: https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/da490c83-d41b-4116-a50a-bf9494179cfa
Source feed: FDA_Inspections

> FDA inspection 963050 of Hetero Drugs Ltd. - Unit 1, February 25, 2016. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963050
- Company Name: Hetero Drugs Ltd. - Unit 1
- Inspection Date: 2016-02-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1269555 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/728fbd7f-8fcd-4259-b230-c3f8aa5ede35)
- FDA Inspection 1121294 - 2020-02-14
- [FDA Inspection 1044698 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/75379504-1534-4c90-a4f5-60c8f64105c9)
- [FDA Inspection 888747 - 2014-05-02](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/d87f37c9-d2fa-4a24-aa5f-a5db6a7d2e40)
- FDA Inspection 700761 - 2010-11-11

Company: https://www.keypedia.com/companies/hetero-drugs-ltd-unit-1/4c15935a-9ff7-4f66-b649-3d78aa3e9753

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c